Hypoxic Preconditioning Protects against Ischemic Brain Injury

NeuroRx

Volumn 1, Issue 1, 2004, Pages 26-35

  Sharp, Frank R ^a,b,c,d   Ran, Ruiqiong ^a,b,c,d   Lu, Aigang ^a,b,c,d   Tang, Yang ^a,b,c,d   Strauss, Kenneth I ^c   Glass, Todd ^b   Ardizzone, Tim ^a,b,c,d   Bernaudin, Myriam ^e  

^a Departments of Neurology   (United States)

^b Pediatrics   (United States)

^c Neurosurgery ^*  (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e UNIVERSITÉ DE CAEN   (France)

Author keywords

EPO; erythropoietin; HIF; Hypoxia; hypoxia inducible factor; ischemia; oxygen; preconditioning; stress proteins; stroke; VEGF

Indexed keywords

COBALT CHLORIDE; DEFEROXAMINE; ERYTHROPOIETIN; GLUCOSE TRANSPORTER; GLYCOLYTIC ENZYME; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; PROTEIN; RNA; TRANSCRIPTION FACTOR EGR 1; VASCULOTROPIN; ARNT PROTEIN, RAT; AROMATIC HYDROCARBON RECEPTOR; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HYPOXIA; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; OXYGEN SENSING; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RNA SYNTHESIS; ANIMAL; BRAIN; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; REVIEW;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BRAIN; BRAIN ISCHEMIA; DNA-BINDING PROTEINS; GENE EXPRESSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING; RATS; RECEPTORS, ARYL HYDROCARBON; TRANSCRIPTION FACTORS;

EID: 18744389551     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1602/neurorx.1.1.26     Document Type: Article

References (172)

1. Hawaleshka A., and Jacobsohn E. Ischaemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth 45 (1998) 670-682
2. Zhu Y., Ohlemiller K., McMahan B., and Gidday J. Mouse models of retinal ischemic tolerance. Invest Ophthalmol Vis Sci 43 (2002) 1903-1911
3. Zimmermann C., Ginis I., Furuya K., Klimanis D., Ruetzler C., Spatz M., and Hallenbeck J. Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain Res 895 (2001) 59-65
4. Barone F., White R., Spera P., Ellison J., Currie R., Wang X., and Feuerstein G. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29 (1998) 1937-1950
5. Blondeau N., Widmann C., Lazdunski M., and Heurteaux C. Activation of the nuclear factor-κB is a key event in brain tolerance. J Neurosci 21 (2001) 4668-4677
6. Bond A., Lodge D., Hicks C., Ward M., and O'Neill M. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus. Eur J Pharmacol 380 (1999) 91-99
7. Chen J., Graham S., Zhu R., and Simon R. Stress proteins and tolerance to focal cerebral ischemia. J Cereb Blood Flow Metab 16 (1996) 566-577
8. Chen J., and Simon R. Ischemic tolerance in the brain. Neurology 48 (1997) 306-311
9. Currie R., Ellison J., White R., Feuerstein G., Wang X., and Barone F. Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res 863 (2000) 169-181
10. Gage A., and Stanton P. Hypoxia triggers neuroprotective alterations in hippocampal gene expression via a heme-containing sensor. Brain Res 719 (1996) 172-178
11. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 22 (2002) 1283-1296
12. Kitagawa K., Matsumoto M., Kuwabara K., Tagaya M., Ohtsuki T., Hata R., et al. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res 561 (1991) 203-211
13. Munoz A., Nakazaki M., Goodman J., Barrios R., Onetti C., Bryan J., and Aguilar-Bryan L. Ischemic preconditioning in the hippocampus of a knockout mouse lacking SUR1-based K(ATP) channels. Stroke 34 (2003) 164-170
14. Neckar J., Papousek F., Novakova O., Ost'adal B., and Kolar F. Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive. Basic Res Cardiol 97 (2002) 161-167
15. Tajima M., Katayose D., Bessho M., and Isoyama S. Acute ischaemic preconditioning and chronic hypoxia independently increase myocardial tolerance to ischaemia. Cardiovasc Res 28 (1994) 312-319
16. Tanaka H., Calderone A., Jover T., Grooms S., Yokota H., Zukin R., and Bennett M. Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampal CA1. Proc Natl Acad Sci USA 99 (2002) 2362-2367
17. Brucklacher R., Vannucci R., and Vannucci S. Hypoxic preconditioning increases brain glycogen and delays energy depletion from hypoxia-ischemia in the immature rat. Dev Neurosci 24 (2002) 411-417
18. Emerson M., Nelson S., Samson F., and Pazdernik T. A global hypoxia preconditioning model: neuroprotection against seizure-induced specific gravity changes (edema) and brain damage in rats. Brain Res Brain Res Protoc 4 (1999) 360-366
19. Emerson M., Nelson S., Samson F., and Pazdernik T. Hypoxia preconditioning attenuates brain edema associated with kainic acid-induced status epilepticus in rats. Brain Res 825 (1999) 189-193
20. Gidday J., Fitzgibbons J., Shah A., and Park T. Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 168 (1994) 221-224
21. Gidday J., Shah A., Maceren R., Wang Q., Pelligrino D., Holtzman D., and Park T. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab 19 (1999) 331-340
22. Miller B., Perez R., Shah A., Gonzales E., Park T., and Gidday J. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 12 (2001) 1663-1669
23. Moolman J., Genade S., Winterbach R., and Lochner A. Preconditioning with hypoxia versus global ischemia in the isolated rat heart: effect on function and metabolism. Cardioscience 5 (1994) 73-80
24. Perez-Pinzon M., Mumford P., Rosenthal M., and Sick T. Anoxic preconditioning in hippocampal slices: role of adenosine. Neuroscience 75 (1996) 687-694
25. Rauca C., Zerbe R., Jantze H., and Krug M. The importance of free hydroxyl radicals to hypoxia preconditioning. Brain Res 868 (2000) 147-149
26. Rubaj A., Gustaw K., Zgodzinski W., Kleinrok Z., and Sieklucka-Dziuba M. The role of opioid receptors in hypoxic preconditioning against seizures in brain. Pharmacol Biochem Behav 67 (2000) 65-70
27. Samoilov M., Lazarevich E., Semenov D., Mokrushin A., Tyul'kova E., Romanovskii D., Milyakova E., and Dudkin K. The adaptive effects of hypoxic preconditioning of brain neurons. Neurosci Behav Physiol 33 (2003) 1-11
28. Sasaki H., Ray P., Zhu L., Otani H., Asahara T., and Maulik N. Hypoxia/reoxygenation promotes myocardial angiogenesis via an NF κB-dependent mechanism in a rat model of chronic myocardial infarction. J Mol Cell Cardiol 33 (2001) 283-294
29. Schurr A., Payne R., Tseng M., Gozal E., and Gozal D. Excitotoxic preconditioning elicited by both glutamate and hypoxia and abolished by lactate transport inhibition in rat hippocampal slices. Neurosci Lett 307 (2001) 151-154
30. Shizukuda Y., Iwamoto T., Mallet R., and Downey H. Hypoxic preconditioning attenuates stunning caused by repeated coronary artery occlusions in dog heart. Cardiovasc Res 27 (1993) 559-564
31. Vannucci R., Towfighi J., and Vannucci S. Hypoxic preconditioning and hypoxic-ischemic brain damage in the immature rat: pathologic and metabolic correlates. J Neurochem 71 (1998) 1215-1220
32. Wen H., Lee C., Lee W., Huang K., and Lin M. Chronic hypoxia preconditioning increases survival in rats suffering from heatstroke. Clin Exp Pharmacol Physiol 29 (2002) 435-440
33. Wick A., Wick W., Waltenberger J., Weller M., Dichgans J., and Schulz J. Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22 (2002) 6401-6407
34. Wu C., Zhan R., Qi S., Fujihara H., Taga K., and Shimoji K. A forebrain ischemic preconditioning model established in C57Black/Crj6 mice. J Neurosci Methods 107 (2001) 101-106
35. Zhang W., and Lu G. Changes of adenosine and its A(1) receptor in hypoxic preconditioning. Biol Signals Recept 8 (1999) 275-280
36. Sharp F., Massa S., and Swanson R. Heat-shock protein protection. Trends Neurosci 22 (1999) 97-99
37. Nishio S., Yunoki M., Chen Z., Anzivino M., and Lee K. Ischemic tolerance in the rat neocortex following hypothermic preconditioning. J Neurosurg 93 (2000) 845-851
38. Riepe M., and Ludolph A. Chemical preconditioning: a cytoprotective strategy. Mol Cell Biochem 174 (1997) 249-254
39. Digicaylioglu M., and Lipton S. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades. Nature 412 (2001) 641-647
40. Ginis I., Jaiswal R., Klimanis D., Liu J., Greenspon J., and Hallenbeck J. TNF-α-induced tolerance to ischemic injury involves differential control of NF-κB transactivation: the role of NF-κB association with p300 adaptor. J Cereb Blood Flow Metab 22 (2002) 142-152
41. Furuya K., Ginis I., Takeda H., Chen Y., and Hallenbeck J. Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. J Cereb Blood Flow Metab 21 (2001) 226-232
42. Bergeron M., Gidday J., Yu A., Semenza G., Ferriero D., and Sharp F. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48 (2000) 285-296
43. Prass K., Ruscher K., Karsch M., Isaev N., Megow D., Priller J., Scharff A., Dirnagl U., and Meisel A. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22 (2002) 520-525
44. Kapinya K., Prass K., and Dirnagl U. Isoflurane-induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism?. Neuroreport 13 (2002) 1431-1435
45. Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K., and Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA 97 (2000) 2264-2269
46. Xi G., Reiser G., and Keep R. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?. J Neurochem 84 (2003) 3-9
47. Bernaudin M., Nedelec A., Divoux D., MacKenzie E., Petit E., and Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22 (2002) 393-403
48. Sharp F., Bergeron M., and Bernaudin M. Hypoxia-inducible factor in brain. Adv Exp Med Biol 502 (2001) 273-291
49. Simon R. Hypoxia versus ischemia. Neurology 52 (1999) 7-8
50. Bergeron M., Yu A., Solway K., Semenza G., and Sharp F. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 11 (1999) 4159-4170
51. Bernaudin M., Tang Y., Reilly M., Petit E., and Sharp F. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 277 (2002) 39728-39738
52. Heurteaux C., Lauritzen I., Widmann C., and Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 92 (1995) 4666-4670
53. Lasley R., Anderson G., and Mentzer Jr. R. Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res 27 (1993) 565-570
54. Tang Y., Lu A., Aronow B., and Sharp F. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 50 (2001) 699-707
55. Tang Y., Lu A., Aronow B., Wagner K., and Sharp F. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 15 (2002) 1937-1952
56. Tang Y., Nee A., Lu A., Ran R., and Sharp F. Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab 23 (2003) 310-319
57. Massa S., Longo F., Zuo J., Wang S., Chen J., and Sharp F. Cloning of rat grp75, an hsp70-family member, and its expression in normal and ischemic brain. J Neurosci Res 40 (1995) 807-819
58. Kietzmann T., Krones-Herzig A., and Jungermann K. Signaling cross-talk between hypoxia and glucose via hypoxia-inducible factor 1 and glucose response elements. Biochem Pharmacol 64 (2002) 903-911
59. Krones A., Jungermann K., and Kietzmann T. Cross-talk between the signals hypoxia and glucose at the glucose response element of the L-type pyruvate kinase gene. Endocrinology 142 (2001) 2707-2718
60. Massa S., Swanson R., and Sharp F. The stress gene response in brain. Cerebrovasc Brain Metab Rev 8 (1996) 95-158
61. Poulaki V., Qin W., Joussen A., Hurlbut P., Wiegand S., Rudge J., Yancopoulos G., and Adamis A. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF. J Clin Invest 109 (2002) 805-815
62. Sharp F. Stress genes protect brain. Ann Neurol 44 (1998) 581-583
63. Sharp F., Lu A., Tang Y., and Millhorn D. Multiple molecular penumbras after focal cerebral ischemia. J Cereb Blood Flow Metab 20 (2000) 1011-1032
64. Ratcliffe P., O'Rourke J., Maxwell P., and Pugh C. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201 (1998) 1153-1162
65. Semenza G. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7 (2001) 345-350
66. Sharp F., Bernaudin M., Bartels M., and Wagner K. Glial expression of heat shock proteins (HSPs) and oxygen-regulated proteins (ORPs). Prog Brain Res 132 (2001) 427-440
67. Emerson M., Samson F., and Pazdernik T. Effects of hypoxia preconditioning on expression of metallothionein-1, 2 and heme oxygenase-1 before and after kainic acid-induced seizures. Cell Mol Biol (Noisy-le-grand) 46 (2000) 619-626
68. Lu G., and Liu H. Downregulation of nitric oxide in the brain of mice during their hypoxic preconditioning. J Appl Physiol 91 (2001) 1193-1198
69. Marber M., and Yellon D. Hypoxic preconditioning of ischaemic myocardium. Cardiovasc Res 26 (1992) 556-557
70. Miyamoto O., and Auer R. Hypoxia, hyperoxia, ischemia, and brain necrosis. Neurology 54 (2000) 362-371
71. Purshottam T., Kaveeshwar U., and Brahmachari H. Hypoxia tolerance in rats in relation to tissue glycogen levels. Aviat Space Environ Med 49 (1978) 1062-1064
72. Riepe M., Esclaire F., Kasischke K., Schreiber S., Nakase H., Kempski O., et al. Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: "chemical preconditioning". J Cereb Blood Flow Metab 17 (1997) 257-264
73. Ruscher K., Isaev N., Trendelenburg G., Weih M., Iurato L., Meisel A., and Dirnagl U. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci Lett 254 (1998) 117-120
74. Shizukuda Y., Mallet R., Lee S., and Downey H. Hypoxic preconditioning of ischaemic canine myocardium. Cardiovasc Res 26 (1992) 534-542
75. Sutter C., Laughner E., and Semenza G. Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci USA 97 (2000) 4748-4753
76. Huang L., and Bunn H. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 278 (2003) 19575-19578
77. Semenza G. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15 (1999) 551-578
78. Ruscher K., Freyer D., Karsch M., Isaev N., Megow D., Sawitzki B., et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 22 (2002) 10291-10301
79. Englander E., Greeley Jr. G., Wang G., Perez-Polo J., and Lee H. Hypoxia-induced mitochondrial and nuclear DNA damage in the rat brain. J Neurosci Res 58 (1999) 262-269
80. Englander E., Hu Z., Sharma A., Lee H., Wu Z., and Greeley G. Rat MYH, a glycosylase for repair of oxidatively damaged DNA, has brain-specific isoforms that localize to neuronal mitochondria. J Neurochem 83 (2002) 1471-1480
81. Lee H., Wang C., Hu Z., Greeley G., Makalowski W., Hellmich H., and Englander E. Hypoxia induces mitochondrial DNA damage and stimulates expression of a DNA repair enzyme, the Escherichia coli MutY DNA glycosylase homolog (MYH), in vivo, in the rat brain. J Neurochem 80 (2002) 928-937
82. Wang G., Hazra T., Mitra S., Lee H., and Englander E. Mitochondrial DNA damage and a hypoxic response are induced by CoCl(2) in rat neuronal PC12 cells. Nucleic Acids Res 28 (2000) 2135-2140
83. Bergeron M., Ferriero D., Vreman H., Stevenson D., and Sharp F. Hypoxia-ischemia, but not hypoxia alone, induces the expression of heme oxygenase-1 (HSP32) in newborn rat brain. J Cereb Blood Flow Metab 17 (1997) 647-658
84. Mole D., Maxwell P., Pugh C., and Ratcliffe P. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. IUBMB Life 52 (2001) 43-47
85. Ratcliffe P. New insights into an enigmatic tumour suppressor. Nat Cell Biol 5 (2003) 7-8
86. Maxwell P., and Ratcliffe P. Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13 (2002) 29-37
87. Semenza G., Nejfelt M., Chi S., and Antonarakis S. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 88 (1991) 5680-5684
88. Semenza G., Roth P., Fang H., and Wang G. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269 (1994) 23757-23763
89. Clifford S., Astuti D., Hooper L., Maxwell P., Ratcliffe P., and Maher E. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma. Oncogene 20 (2001) 5067-5074
90. Cockman M., Masson N., Mole D., Jaakkola P., Chang G., Clifford S., et al. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275 (2000) 25733-25741
91. Hon W., Wilson M., Harlos K., Claridge T., Schofield C., Pugh C., et al. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature 417 (2002) 975-978
92. Huang L., Gu J., Schau M., and Bunn H. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95 (1998) 7987-7992
93. Iliopoulos O., Levy A., Jiang C., Kaelin Jr. W., and Goldberg M. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93 (1996) 10595-10599
94. Ivan M., and Kaelin Jr. W. The von Hippel-Lindau tumor suppressor protein. Curr Opin Genet Dev 11 (2001) 27-34
95. Jaakkola P., Mole D., Tian Y., Wilson M., Gielbert J., Gaskell S., et al. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
96. Kamura T., Sato S., Haque D., Liu L., Kaelin Jr. W., Conaway R., and Conaway J. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 12 (1998) 3872-3881
97. Maher E., and Kaelin Jr. W. von Hippel-Lindau disease. Med (Baltimore) 76 (1997) 381-391
98. Maxwell P., Wiesener M., Chang G., Clifford S., Vaux E., Cockman M., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
99. Ohh M., Park C., Ivan M., Hoffman M., Kim T., Huang L., Pavletich N., Chau V., and Kaelin W. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2 (2000) 423-427
100. Ohh M., Takagi Y., Aso T., Stebbins C., Pavletich N., Zbar B., et al. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. J Clin Invest 104 (1999) 1583-1591
101. Arany Z., Huang L., Eckner R., Bhattacharya S., Jiang C., Goldberg M., Bunn H., and Livingston D. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93 (1996) 12969-12973
102. Kung A., Wang S., Klco J., Kaelin W., and Livingston D. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 6 (2000) 1335-1340
103. O'Rourke J., Dachs G., Gleadle J., Maxwell P., Pugh C., Stratford I., et al. Hypoxia response elements. Oncol Res 9 (1997) 327-332
104. Semenza G., Jiang B., Leung S., Passantino R., Concordet J., Maire P., and Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271 (1996) 32529-32537
105. Vaux E., Wood S., Cockman M., Nicholls L., Yeates K., Pugh C., et al. Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor. J Biol Chem 276 (2001) 44323-44330
106. Jones N., and Bergeron M. Hypoxic preconditioning induces changes in HIF-1 target genes in neonatal rat brain. J Cereb Blood Flow Metab 21 (2001) 1105-1114
107. Elkins J., Hewitson K., McNeill L., Seibel J., Schlemminger I., Pugh C., et al. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1α. J Biol Chem 278 (2003) 1802-1806
108. Epstein A., Gleadle J., McNeill L., Hewitson K., O'Rourke J., Mole D., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
109. Freedman S., Sun Z., Poy F., Kung A., Livingston D., Wagner G., and Eck M. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci USA 99 (2002) 5367-5372
110. Hewitson K., McNeill L., Riordan M., Tian Y., Bullock A., Welford R., et al. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277 (2002) 26351-26355
111. Ivan M., Haberberger T., Gervasi D., Michelson K., Gunzler V., Kondo K., et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA 99 (2002) 13459-13464
112. Masson N., Willam C., Maxwell P., Pugh C., and Ratcliffe P. Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. Embo J 20 (2001) 5197-5206
113. Min J., Yang H., Ivan M., Gertler F., Kaelin Jr. W., and Pavletich N. Structure of an HIF-1α -pVHL complex: hydroxyproline recognition in signaling. Science 296 (2002) 1886-1889
114. Zhu H., and Bunn H. Signal transduction. How do cells sense oxygen?. Science 292 (2001) 449-451
115. Semenza G. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 54 (2003) 17-28
116. Semenza G. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 1 (2000) 159-162
117. Chavez J., and LaManna J. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci 22 (2002) 8922-8931
118. Zundel W., Schindler C., Haas-Kogan D., Koong A., Kaper F., Chen E., et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14 (2000) 391-396
119. Oikawa M., Abe M., Kurosawa H., Hida W., Shirato K., and Sato Y. Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res Commun 289 (2001) 39-43
120. Sanchez-Elsner T., Botella L., Velasco B., Corbi A., Attisano L., and Bernabeu C. Synergistic cooperation between hypoxia and transforming growth factor-β pathways on human vascular endothelial growth factor gene expression. J Biol Chem 276 (2001) 38527-38535
121. Yin J., Yang D., Ku G., and Hsu C. iNOS expression inhibits hypoxia-inducible factor-1 activity. Biochem Biophys Res Commun 279 (2000) 30-34
122. Okada M., Fujita T., Sakaguchi T., Olson K., Collins T., Stern D., Yan S., and Pinsky D. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. FASEB J 15 (2001) 2757-2759
123. Yan S., Fujita T., Lu J., Okada K., Shan Zou Y., Mackman N., et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 6 (2000) 1355-1361
124. Yan S., Lu J., Zou Y., Soh-Won J., Cohen D., Buttrick P., et al. Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 274 (1999) 15030-15040
125. Yan S., Pinsky D., and Stern D. A pathway leading to hypoxia-induced vascular fibrin deposition. Semin Thromb Hemost 26 (2000) 479-483
126. Yan S., Zou Y., Gao Y., Zhai C., Mackman N., Lee S., et al. Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 95 (1998) 8298-8303
127. Millhorn D., Beitner-Johnson D., Conforti L., Conrad P., Kobayashi S., Yuan Y., and Rust R. Gene regulation during hypoxia in excitable oxygen-sensing cells: depolarization-transcription coupling. Adv Exp Med Biol 475 (2000) 131-142
128. Schnell P., Ignacak M., Bauer A., Striet J., Paulding W., and Czyzyk-Krzeska M. Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors. J Neurochem 85 (2003) 483-491
129. Bianchi L., Tacchini L., and Cairo G. HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. Nucleic Acids Res 27 (1999) 4223-4227
130. Kietzmann T., Samoylenko A., Roth U., and Jungermann K. Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. Blood 101 (2003) 907-914
131. Lu S., Gu X., Hoestje S., and Epner D. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim Biophys Acta 1574 (2002) 152-156
132. Minchenko A., and Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem 208 (2000) 53-62
133. Miyazaki K., Kawamoto T., Tanimoto K., Nishiyama M., Honda H., and Kato Y. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem 277 (2002) 47014-47021
134. Alafaci C., Salpietro F., Grasso G., Sfacteria A., Passalacqua M., Morabito A., Tripodo E., Calapai G., Buemi M., and Tomasello F. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur J Pharmacol 406 (2000) 219-225
135. Bernaudin M., Marti H., Roussel S., Divoux D., Nouvelot A., MacKenzie E., and Petit E. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19 (1999) 643-651
136. Brines M., Ghezzi P., Keenan S., Agnello D., de Lanerolle N., Cerami C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97 (2000) 10526-10531
137. Buemi M., Cavallaro E., Floccari F., Sturiale A., Aloisi C., Trimarchi M., et al. Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin Sci (Lond) 103 (2002) 275-282
138. Calvillo L., Latini R., Kajstura J., Leri A., Anversa P., Ghezzi P., et al. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 100 (2003) 4802-4806
139. Carmeliet P., Dor Y., Herbert J., Fukumura D., Brusselmans K., Dewerchin M., et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394 (1998) 485-490
140. Catania M., Marciano M., Parisi A., Sturiale A., Buemi M., Grasso G., et al. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol 437 (2002) 147-150
141. Celik M., Gokmen N., Erbayraktar S., Akhisaroglu M., Konakc S., Ulukus C., et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 99 (2002) 2258-2263
142. Ehrenreich H., Hasselblatt M., Dembowski C., Cepek L., Lewczuk P., Stiefel M., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8 (2002) 495-505
143. Grasso G. Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J Neurosurg Sci 45 (2001) 7-14
144. Kumral A., Ozer E., Yilmaz O., Akhisaroglu M., Gokmen N., Duman N., et al. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol Neonate 83 (2003) 224-228
145. Sadamoto Y., Igase K., Sakanaka M., Sato K., Otsuka H., Sakaki S., et al. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 253 (1998) 26-32
146. Sakanaka M., Wen T., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95 (1998) 4635-4640
147. Solaroglu I., Solaroglu A., Kaptanoglu E., Dede S., Haberal A., Beskonakli E., and Kilinc K. Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 19 (2003) 19-22
148. Fink S., Ho D., McLaughlin J., and Sapolsky R. An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid. Brain Res 859 (2000) 21-25
149. Gupta A., Ho D., Brooke S., Franklin L., Roy M., McLaughlin J., Fink S., and Sapolsky R. Neuroprotective effects of an adenoviral vector expressing the glucose transporter: a detailed description of the mediating cellular events. Brain Res 908 (2001) 49-57
150. Lawrence M., Ho D., Dash R., and Sapolsky R. Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. Proc Natl Acad Sci USA 92 (1995) 7247-7251
151. Forsythe J., Jiang B., Iyer N., Agani F., Leung S., Koos R., and Semenza G. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 (1996) 4604-4613
152. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28 (2001) 131-138
153. Zaman K., Ryu H., Hall D., O'Donovan K., Lin K., Miller M., et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J Neurosci 19 (1999) 9821-9830
154. Schipani E., Ryan H., Didrickson S., Kobayashi T., Knight M., and Johnson R. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev 15 (2001) 2865-2876
155. Dong Z., Nishiyama J., Yi X., Venkatachalam M., Denton M., Gu S., Li S., and Qiang M. Gene promoter of apoptosis inhibitory protein IAP2: identification of enhancer elements and activation by severe hypoxia. Biochem J 364 (2002) 413-421
156. Fan C., Li Q., Ross D., and Engelhardt J. Tyrosine phosphorylation of I κB α activates NF κB through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. J Biol Chem 278 (2003) 2072-2080
157. Green C., Lichtlen P., Huynh N., Yanovsky M., Laderoute K., Schaffner W., and Murphy B. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 61 (2001) 2696-2703
158. Jung Y., Isaacs J., Lee S., Trepel J., Liu Z., and Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor κB activation. Biochem J 370 (2003) 1011-1017
159. Jung Y., Isaacs J., Lee S., Trepel J., and Neckers L. Microtubule disruption utilizes an NFκB-dependent pathway to stabilize HIF-1α protein. J Biol Chem 278 (2003) 7445-7452
160. Liu Y., Cox S., Morita T., and Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 77 (1995) 638-643
161. Houston P., Dickson M., Ludbrook V., White B., Schwachtgen J., McVey J., et al. Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. Arterioscler Thromb Vasc Biol 19 (1999) 281-289
162. Silverman E., Le L., Baron R., Hallock A., Hjoberg J., Shikanai T., et al. Cloning and functional analysis of the mouse 5-lipoxygenase promoter. Am J Respir Cell Mol Biol 26 (2002) 475-483
163. Wilder P., Bernadt C., Kim J., and Rizzino A. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1. Mol Reprod Dev 63 (2002) 282-290
164. Cramer T., Yamanishi Y., Clausen B., Forster I., Pawlinski R., Mackman N., et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112 (2003) 645-657
165. An W., Kanekal M., Simon M., Maltepe E., Blagosklonny M., and Neckers L. Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 392 (1998) 405-408
166. Blagosklonny M., An W., Romanova L., Trepel J., Fojo T., and Neckers L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273 (1998) 11995-11998
167. Brusselmans K., Bono F., Maxwell P., Dor Y., Dewerchin M., Collen D., et al. Hypoxia-inducible factor-2α (HIF-2α) is involved in the apoptotic response to hypoglycemia but not to hypoxia. J Biol Chem 276 (2001) 39192-39196
168. Halterman M., Miller C., and Federoff H. Hypoxia-inducible factor-1α mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci 19 (1999) 6818-6824
169. Flavin M., and Zhao G. Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury. J Neurosci Res 63 (2001) 388-394
170. Klein G., Li H., Sun P., and Buchan A. Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia. Neurology 52 (1999) 1381-1384
171. Tsirka S. Tissue plasminogen activator as a modulator of neuronal survival and function. Biochem Soc Trans 30 (2002) 222-225
172. Wang Y., Tsirka S., Strickland S., Stieg P., Soriano S., and Lipton S. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4 (1998) 228-231